Increasing Geriatric Population Fuels Demand in U.S. External Catheter Industry

The U.S. external catheter market has emerged as a critical segment within the broader urological devices industry, driven by an aging population, rising prevalence of urinary incontinence, and increasing preference for non-invasive, discreet management solutions. Valued at USD 1.11 billion in 2024, the market is projected to grow at a compound annual growth rate (CAGR) of 6.4% from 2025 to 2034, according to data from the U.S. Department of Health and Human Services (HHS) and the Centers for Disease Control and Prevention (CDC). This sustained expansion reflects growing awareness among healthcare providers and patients about the benefits of external catheters—also known as condom catheters or urinary sheaths—over indwelling alternatives, particularly in reducing the risk of urinary tract infections (UTIs), enhancing patient comfort, and supporting independent living. As home healthcare gains prominence and Medicare reimbursement policies evolve to favor outpatient care, demand for reliable, user-friendly external catheter systems continues to strengthen across both clinical and domestic settings.

Market dynamics are shaped by a combination of demographic, clinical, and regulatory factors that vary significantly across regions, influencing adoption rates, product innovation, and distribution strategies. A primary driver in North America is the aging demographic profile, with the U.S. Census Bureau reporting that over 17% of the population—approximately 58 million individuals—were aged 65 or older in 2024, a figure expected to rise to 22% by 2030. This demographic shift correlates with higher incidences of neurogenic bladder, prostate-related conditions, and mobility impairments, all of which increase the need for effective urinary management. The Veterans Health Administration (VHA), one of the largest purchasers of urological devices in the U.S., has implemented standardized procurement protocols that prioritize latex-free, anti-leakage, and skin-protective external catheters, setting a benchmark for product quality and influencing private sector demand. However, challenges remain, including inconsistent insurance coverage under Medicare Part B for certain catheter accessories and variability in clinician training, which can affect proper fitting and long-term adherence.

In Europe, the external catheter market is characterized by a more fragmented regulatory landscape but strong public health infrastructure that supports device accessibility. Countries such as Germany, the United Kingdom, and Sweden have established national guidelines for incontinence care through agencies like the National Institute for Health and Care Excellence (NICE) and the German Federal Joint Committee (G-BA), promoting early intervention and non-surgical options. Eurostat data indicates that 20% of adults over 60 in the EU report some form of urinary incontinence, creating a substantial patient pool. Reimbursement mechanisms vary: Germany’s statutory health insurance (GKV) covers external catheters under fixed-service packages, while in the UK, provision is often managed at the local Clinical Commissioning Group (CCG) level, leading to regional disparities in availability. Despite these inconsistencies, the European market benefits from robust home healthcare networks and growing emphasis on patient dignity and quality of life, driving demand for advanced materials such as silicone-based sheaths and hydrophobic coatings that reduce skin irritation and improve adhesion.

As the market evolves, competition is intensifying among established medical device firms with strong distribution networks and regulatory expertise. The convergence of demographic pressure, healthcare decentralization, and product innovation positions the external catheter segment for sustained growth, particularly in regions where aging populations and healthcare modernization align.